Coxswain Bio Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 10-12-2024
- Revenue 5.92%
(FY 2017)
- Profit -7.92%
(FY 2017)
- Ebitda -579.43%
(FY 2017)
- Net Worth 9.81%
(FY 2017)
- Total Assets 20.42%
(FY 2017)
About Coxswain Bio Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Kanish Vasudeva and Alok Vasudeva serve as directors at the Company.
- CIN/LLPIN
U74140HR2009PTC039362
- Company No.
039362
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Aug 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Hisar, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Coxswain Bio Remedies Private Limited offer?
Coxswain Bio Remedies Private Limited offers a wide range of products and services, including Antipyretic Medication, Disprin Tablet, Paracetamol Tablets, Combiflam Tablet, Vitamin Tablets & Capsules, Vitamin C Tablets & Capsules.
Who are the key members and board of directors at Coxswain Bio Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanish Vasudeva  | Director | 07-Aug-2009 | Current |
| Alok Vasudeva | Director | 07-Aug-2009 | Current |
Financial Performance of Coxswain Bio Remedies.
Coxswain Bio Remedies Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 5.92% increase. The company also saw a slight decrease in profitability, with a 7.92% decrease in profit. The company's net worth moved up by a moderate rise of 9.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Coxswain Bio Remedies?
In 2017, Coxswain Bio Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 May 2017 | ₹1.00 M | Open |
How Many Employees Work at Coxswain Bio Remedies?
Unlock and access historical data on people associated with Coxswain Bio Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Coxswain Bio Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Coxswain Bio Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
